U.S. Veterinary Oncology Diagnostics Market is projected to reach USD 2,228.87 billion by 2034, expanding at a compound annual growth rate (CAGR) of 8.4%.

U.S. Veterinary Oncology Diagnostics Market

Polaris Market Research projects the global U.S. veterinary oncology diagnostics market to reach a valuation of nearly USD 2,228.87 billion by the end of 2034 from USD 992.64 billion in 2024, with a CAGR of 8.4% during the forecast period from 2025 to 2034.

Market Explanation

Veterinary oncology diagnostics refer to the specialized tools, techniques, and procedures used to detect, identify, and monitor cancer in animals, particularly companion pets such as dogs and cats. These diagnostics play a critical role in early cancer detection, treatment planning, and disease management. Common diagnostic methods include physical examinations, imaging technologies (such as X-rays, ultrasounds, and MRIs), biopsy and cytology, blood tests, and molecular diagnostics.

Given the relatively short lifespans of companion animals, cancer incidence rates, especially in older pets-, be higher on an annual basis than in humans. For instance, nearly half of all dogs over the age of ten are expected to develop cancer, with skin tumors being the most frequently diagnosed. In cats, a similarly high rate of malignancy is observed in skin tumors. These patterns underscore the urgent need for advanced and reliable veterinary oncology diagnostics to improve prognosis and guide timely interventions.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/us-veterinary-oncology-diagnostics-market/request-for-sample

Market Drivers

Growing Rate of Pet Ownership: The growing rate of pet possession in the US together with escalation of the human animal bond drives market demand. Roughly 66% of homes in the US own a pet, relating to over 86.9 million homes. Dogs and cats are the most approved companion animals. In 2023, aggregate pet care disbursement in the US hit USD 136.8 billion, a notable surge from former years. This, in turn, is driving the U.S. veterinary oncology diagnostics market growth.

Technological Progressions: The ongoing progressions in veterinary diagnostic technologies is a major market driver. Innovations in imaging, laboratory testing, and molecular diagnostics are offering veterinarians with additional precise, speedier and minimally invasive procedures for inspecting and identifying cancer in animals.

Company Insights

The market presents a consolidated and competitive landscape, comprising both well-established and emerging veterinary diagnostic companies. Key players profiled in the report include:

• Antech Diagnostics, Inc. (Mars Inc.)
• CANCAN DIAGNOSTICS
• Embark Veterinary, Inc
• Gold Standard Diagnostics (Eurofins Technologies)
• IDEXX Laboratories, Inc.
• Neogen Corporation
• Oncotect
• PetDx
• VolitionRx Limited
• Zoetis

Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/us-veterinary-oncology-diagnostics-market/inquire-before-buying

U.S. Veterinary Oncology Diagnostics Market Report Highlights:

📚 By animal type, the canine segment currently holds the largest market share in the U.S. Veterinary Oncology Diagnostics Market, primarily due to the higher incidence of cancer in dogs and their larger population as companion animals across the United States. This substantial segment reflects the strong inclination of dog owners to pursue advanced diagnostics for their pets when faced with a cancer diagnosis.
📚 By test type, the imaging segment currently accounts for the largest share of the U.S. Veterinary Oncology Diagnostics Market, driven by the widespread and crucial role of various imaging modalities like radiography, ultrasound, CT, and MRI in the initial detection and staging of a broad range of cancers in animal patients throughout the United States.
📚 By cancer type, the lymphoma segment currently represents the largest share of the U.S. Veterinary Oncology Diagnostics Market. This is mainly due to the relatively high occurrence of lymphoma in both canine and feline populations within the United States, making it one of the most frequently diagnosed cancers in veterinary practice nationwide.
📚 By end use, the reference laboratories segment currently holds the largest share of the U.S. Veterinary Oncology Diagnostics Market. This is because a significant volume of specialized and complex cancer diagnostic testing, particularly advanced molecular analyses and histopathology, is outsourced by veterinary hospitals and clinics across the United States to these specialized facilities.

Market Segmentation

The U.S. veterinary oncology diagnostics market is broadly segmented based on animal type, test type, cancer type and end use.

Based on animal type, the canine segment holds the largest market share, driven by growing existence of cancer in canines as contrasted to other companion animals.

Based on test type, the imaging segment accounts for the largest market share owing to the extensive usage of several imaging modalities such as ultrasound, radiography, MRI and CT scans.

Explore The Complete Report:
https://www.polarismarketresearch.com/industry-analysis/us-veterinary-oncology-diagnostics-market

Regional Insights

North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Frequently Asked Questions (FAQs)

1. What are the key statistics of the U.S. veterinary oncology diagnostics market?
2. What is the current growth rate of the U.S. veterinary oncology diagnostics market?
3. Who are the major players in the U.S. veterinary oncology diagnostics market?
4. Which animal type segment held the largest market share in 2024?
5. What are the emerging trends and future opportunities in the U.S. veterinary oncology diagnostics market?
6. What does U.S. veterinary oncology diagnostics entail?

More Trending Reports by Polaris Market Research:

Autoinjectors Market:
https://www.polarismarketresearch.com/industry-analysis/autoinjectors-market

Veterinary Pharmacovigilance Market:
https://www.polarismarketresearch.com/industry-analysis/veterinary-pharmacovigilance-market

Clinical Trial Technology and Services Market:
https://www.polarismarketresearch.com/industry-analysis/clinical-trial-technology-and-services-market

Peptide Synthesis Market:
https://www.polarismarketresearch.com/industry-analysis/peptide-synthesis-market

Leading Top 5 Companies Innovating in Vitamin B3 Manufacturing:
https://www.polarismarketresearch.com/blog/leading-top-5-companies-innovating-in-vitamin-b3-manufacturing

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.